Company · CIK 0001730430 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Kiniksa Pharmaceuticals International, plc · KNSA

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $0 · 0sales $369k · 1net −$369k

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Sep 3, 2026 SForm 4 →	Sep 3, 4:40 pm EDT	Michael R MegnaCHIEF ACCOUNTING OFFICER	4,600	$80.30	$369,380	29,062	−13.7%	10b5-1
Sep 1, 2026 FMForm 4 →	Sep 3, 4:49 pm EDT	Mark RagosaCHIEF FINANCIAL OFFICER	13,508	$79.28	$349,149	20,854	—
Sep 1, 2026 FMForm 4 →	Sep 3, 4:48 pm EDT	Sanj K PatelCHAIRMAN & CEO, Director	46,462	$79.28	$1,200,616	92,348	—
Sep 1, 2026 FMForm 4 →	Sep 3, 4:46 pm EDT	Sanj K PatelCHAIRMAN & CEO, Director	46,462	$79.28	$1,200,616	92,348	—
Sep 1, 2026 FMForm 4 →	Sep 3, 4:43 pm EDT	John F. PaoliniCHIEF MEDICAL OFFICER	12,357	$79.28	$319,419	69,922	—
Sep 1, 2026 FMForm 4 →	Sep 3, 4:41 pm EDT	Ross MoatCHIEF OPERATING OFFICER	12,292	$79.28	$317,675	16,307	—

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Δ stake	Flags
Sep 1, 2026 AMForm 4 →	Sep 3, 4:49 pm EDT	Mark RagosaCHIEF FINANCIAL OFFICER	48,054	—	—	—
Sep 1, 2026 AMForm 4 →	Sep 3, 4:48 pm EDT	Sanj K PatelCHAIRMAN & CEO, Director	181,518	—	—	—
Sep 1, 2026 AMForm 4 →	Sep 3, 4:46 pm EDT	Sanj K PatelCHAIRMAN & CEO, Director	181,518	—	—	—
Sep 1, 2026 AMForm 4 →	Sep 3, 4:43 pm EDT	John F. PaoliniCHIEF MEDICAL OFFICER	41,778	—	—	—
Sep 1, 2026 AMForm 4 →	Sep 3, 4:41 pm EDT	Ross MoatCHIEF OPERATING OFFICER	54,485	—	—	—
Sep 1, 2026 AMForm 4 →	Sep 3, 4:40 pm EDT	Michael R MegnaCHIEF ACCOUNTING OFFICER	29,746	—	—	—	10b5-1